Magnetic Resonance Imaging of Interscalene Plexus Block

NCT02175069 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Disorder of Shoulder

Interventions

PROCEDURE: Interscalene Nerve Block
DRUG: Ropivacaine 0.75%, 20ml
DRUG: Gadopentetate-Dimeglumine 0.0125 mmol
DRUG: Gadopentetate-Dimeglumine 0.05 mmol
DRUG: Ropivacaine 0.75%, 5ml
PROCEDURE: Shoulder Surgery

Sponsor

Paracelsus Medical University